Hypnosis and Direct Autonomic Experience Influence on Chronic Symptoms
NCT ID: NCT04303143
Last Updated: 2020-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2021-03-31
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Purpose is to confirm that DAX generally appears to impact SUDS value and subjects report observed level of effect on short and longer term measurements.
Most significantly, testing that DAX technique/action is reusable later if the measured SUDS value returns or increases.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-intensity Focused Ultrasound and Autonomic Response
NCT05834829
Transauricular Vagal Nerve Stimulation, Pressure Pain and Interoception
NCT06240026
Non-invasive Modulation of Autonomic Cardiac Nervous System
NCT04057508
Vagal Nerve Stimulation to Treat Disorders of Consciousness
NCT07077135
The Effects of taVNS on Inhibitory Control
NCT05468385
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
DAX is designed to be adaptive such that as matters that affected the initial SUDS conditions may have changed, shifted, grown or otherwise be different.
(Examples are increased lesions with MS). Where initial patterns were created with a certain set of neural condition and pathways. But now days/weeks later, with new pathways created, can a previously installed DAX pattern adjust and shift to accommodate the new neural patterns based on participants willingness and self-instruction, or does it require professional adjustment.
Example participant given strong post-hypnotic suggestions/anchor/etc to squeeze right hand in certain way to bring relief to leg discomfort. Initial testing shows working. Now time has shifted, maybe new pathways or other chronic conditions have changed. Can the DAX processes the participant has been taught handle these changes or does it require a professional to re-apply/boost or incorporate new details to get significant changes to reported SUDS discomfort values.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Primary
Primary
Self-Hypnosis
Self-Hypnosis
Direct Autonomic Experience Control
Direct Autonomic Experience Control. Use of learned mental tool/process to affect outcome measure of SUDS discomfort experience. (eg. Squeeze hand as pre-learned mental anchor to relieve discomfort in lower legs)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self-Hypnosis
Self-Hypnosis
Direct Autonomic Experience Control
Direct Autonomic Experience Control. Use of learned mental tool/process to affect outcome measure of SUDS discomfort experience. (eg. Squeeze hand as pre-learned mental anchor to relieve discomfort in lower legs)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Existing medical treatments are having little to no effect on a discomfort metric to measure
* SUDS to be evaluated could be physical or emotional in nature (e.g. Anxiety level, or Leg Cramping/moving)
* Must be motivated and willing to participate in a study that uses hypnosis, placebo and/or nocebo type mental matters.
* Participant must continue existing medical treatments (as recommended/adjusted by such outside professionals) and continue to see and be monitored by new/existing medical professionals during the term of study.
* Must have technology of computers/internet/support to be able to attend regular video chat/conferences for needed interactions with study.
* Must have schedule availability and flexibility to meet in video chats/conferences as required.
* Must have the computer skills/resources and aptitude to handle video chat/conference and able to have resources/friends/knowledge that can help if technical issues arise to allow conference to occur (can handle restarting a video conference if crashes or network acts up)
Exclusion Criteria
* Must not be active in any other studies or such studies deemed to not interact with this.
* Does not have a properly diagnosed chronic condition (exception are control subjects)
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inner Group Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Vendemia, BCH, MNLP
Role: PRINCIPAL_INVESTIGATOR
Inner Group Inc.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HypDax1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.